Evaluation of a real-time PCR assay for the detection of the klebsiella pneumoniae carbapenemase genes in microbiological samples in comparison with the modified hodge test

American Journal of Clinical Pathology

Volumn 135, Issue 4, 2011, Pages 566-571

  Raghunathan, Aditya ^a   Samuel, Linoj ^a   Tibbetts, Robert J ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

BlaKPC genes; Klebsiella pneumoniae carbapenemase; KP.C.; Modified Hodge test

Indexed keywords

CARBAPENEMASE; ERTAPENEM; IMIPENEM;

ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DNA SEQUENCE; DRUG RESISTANCE; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC ANALYSIS; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE CARBAPENEMASE GENE; MODIFIED HODGE TEST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERRATIA MARCESCENS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; DNA, BACTERIAL; GENES, BACTERIAL; HUMANS; IMIPENEM; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS;

EID: 79954602872     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPPVNUI3O9JHJW     Document Type: Article

References (39)

1. Zanetti G, Bally F, Greub G, et al. Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: A multicenter, evaluator-blind, prospective, randomized study. Antimicrob Agents Chemother. 2003;47:3442-3447. (Pubitemid 37345702)
2. Deshpande LM, Rhomberg PR, Sader HS, et al. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States medical centers: Report from the MYSTIC Program (1999-2005). Diagn Microbiol Infect Dis. 2006;56:367-372. (Pubitemid 44854361)
3. Deshpande LM, Jones RN, Fritsche TR, et al. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb Drug Resist. 2006;12:223-230. (Pubitemid 46110652)
4. Leavitt A, Navon-Venezia S, Chmelnitsky I, et al. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae in an Israeli hospital. Antimicrob Agents Chemother. 2007;51:3026-3029. (Pubitemid 47206254)
5. Naas T, Nordmann P, Vedel G, et al. Plasmid-mediated carbapenem- hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France [letter]. Antimicrob Agents Chemother. 2005;49:4423-4424. (Pubitemid 41401006)
6. Samra Z, Ofir O, Lishtzinsky Y, et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents. 2007;30:525-529. (Pubitemid 350064465)
7. Tenover FC, Kalsi RK, Williams PP, et al. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis. 2006;12:1209-1213.
8. Villegas MV, Lolans K, Correa A, et al. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother. 2006;50:2880-2882. (Pubitemid 44198721)
9. Yigit H, Queenan AM, Rasheed JK, et al. Carbapenemresistant strain of Klebsiella oxytoca harboring carbapenemhydrolyzing beta-lactamase KPC-2. Antimicrob Agents Chemother. 2003;47:3881-3889. (Pubitemid 37485004)
10. Bradford PA, Bratu S, Urban C, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem hydrolyzing KPC-2 and inhibitor-resistant TEM-30 ǎ-lactamases in New York City. Clin Infect Dis. 2004;39:55-60. (Pubitemid 38879549)
11. Lomaestro BM, Tobin EH, Shang W. The spread of Klebsiella pneumoniae carbapenemase-producing K pneumoniae to upstate New York. Clin Infect Dis. 2006;43:e26-e28. doi:10.1086/505598.
12. Nordmann P, Poirel L. Emerging carbapenemases in gram negative aerobes. Clin Microbiol Infect. 2002;8:321-331. (Pubitemid 34993804)
13. Woodford N, Tierno PM Jr, Young K, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenemhydrolyzing class A ǎ-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother. 2004;48:4793-4799. (Pubitemid 39577686)
14. Bonnet R, Marchandin H, Chanal C, et al. Chromosomeencoded class D ǎ-lactamase OXA-23 in Proteus mirabilis. Antimicrob Agents Chemother. 2002;46:2004-2006. (Pubitemid 34535232)
15. Bratu S, Landman D, Alam M, et al. Detection of KPC carbapenem- hydrolyzing enzymes in Enterobacter spp from Brooklyn, New York. Antimicrob Agents Chemother.2005;49:776-778. (Pubitemid 40175694)
16. Hossain A, Ferraro MJ, Pino RM, et al. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob Agents Chemother. 2004;48:4438-4440. (Pubitemid 39434910)
17. Miriagou V, Tzouvelekis LS, Rossiter S, et al. Imipenem resistance in a Salmonella clinical strain due to plasmidmediated class A carbapenemase KPC-2. Antimicrob Agents Chemother. 2003;47:1297-1300. (Pubitemid 36368588)
18. Navon-Venezia S, Chmelnitsky I, Leavitt A, et al. Plasmidmediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother. 2006;50:3098-3101. (Pubitemid 44396417)
19. Samra Z, Bahar J, Madar-Shapiro L, et al. Evaluation of CHROMagar KPC for rapid detection of carbapenemresistant Enterobacteriaceae. J Clin Microbiol. 2008;46:3110-3111.
20. Tibbetts R, Frye JG, Marschall J, et al. Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC ǎ-lactamase in P mirabilis. J Clin Microbiol. 2008;46:3080-3083.
21. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45:1151-1161. (Pubitemid 32230996)
22. Bratu S, Brooks S, Burney S, et al. Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin Infect Dis. 2007;44:972-975. (Pubitemid 46452064)
23. Wei ZQ, Du XX, Yu YS, et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007;51:763-765.
24. Alba J, Ishii Y, Thomson EK, et al. Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing betalactamase. Antimicrob Agents Chemother. 2005;49:4760-4762. (Pubitemid 41552612)
25. Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: A new threat to our antibiotic armamentarium. Arch Intern Med. 2005;165:1430-1435. (Pubitemid 40973427)
26. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; M100-S19 checklist. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
27. Bratu S, Tolaney P, Karumudi U, et al. Carbapenemaseproducing Klebsiella pneumoniae in Brooklyn, NY: Molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother. 2005;56:128-132. (Pubitemid 41418346)
28. Cole JM, Schuetz AN, Hill CE, et al. Development and evaluation of a real-time PCR assay for detection of Klebsiella pneumoniae carbapenemase genes. J Clin Microbiol. 2009;47:322-326.
29. Hindiyeh M, Smollen G, Grossman Z, et al. Rapid detection of blaKPC carbapenemase genes by real-time PCR. J Clin Microbiol. 2008;46:2879-2883.
30. Schechner V, Straus-Robinson K, Schwartz D, et al. Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family. J Clin Microbiol. 2009;47:3261-3265.
31. Pasteran F, Mendez T, Guerriero L, et al. Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol. 2009;47:1631-1639.
32. Carvalhaes CG, Picão RC, Nicoletti AG, et al. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: Be aware of false positive results. J Antimicrob Chemother. 2009;65:249-251.
33. Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid-mediated AmpC ǎ-lactamases in Enterobacteriaceae lacking chromosomal AmpC ǎ-lactamases. J Clin Microbiol. 2005;43:3110-3113. (Pubitemid 40981309)
34. Lee K, Chong Y, Shin HB, et al. Modified Hodge and EDTAdisk synergy tests to screen metallo-ǎ-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2001;7:88-91. (Pubitemid 34960278)
35. Cao VT, Arlet G, Ericsson BM, et al. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J Antimicrob Chemother. 2000;46:895-900. (Pubitemid 32000598)
36. Crowley B, Benedí VJ, Doménech-Sánchez A. Expression of SHV-2 ǎ-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems. Antimicrob Agents Chemother. 2002;46:3679-3682. (Pubitemid 35192952)
37. Pasteran F, Mendez T, Rapoport M, et al. Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class A carbapenemase in species of Enterobacteriaceae by incorporating boronic acid. J Clin Microbiol. 2010;48:1323-1332.
38. Clinical and Laboratory Standards Institute. M100-S20: Update performance standards for antimicrobial susceptibility testing, M100-S20U. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
39. Daikos G, Petrikkos P, Psichogiou M, et al. Prospective observational study of the impact of VIM-1 metallo- ǎ-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother. 2009;53:1868-1873.